Palbociclib for HR-Positive, HER2-Positive Breast Cancer. Reply

N Engl J Med. 2026 Apr 30;394(17):1765-1766. doi: 10.1056/NEJMc2602522.
No abstract available

Publication types

  • Letter
  • Comment